CA2202496C - Peptides neurotrophiques du facteur neurotrophique dependant de l'activite - Google Patents

Peptides neurotrophiques du facteur neurotrophique dependant de l'activite Download PDF

Info

Publication number
CA2202496C
CA2202496C CA002202496A CA2202496A CA2202496C CA 2202496 C CA2202496 C CA 2202496C CA 002202496 A CA002202496 A CA 002202496A CA 2202496 A CA2202496 A CA 2202496A CA 2202496 C CA2202496 C CA 2202496C
Authority
CA
Canada
Prior art keywords
gly
amino acid
adnf
acid sequence
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002202496A
Other languages
English (en)
Other versions
CA2202496A1 (fr
Inventor
Douglas E. Brenneman
Illana Gozes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ramot at Tel Aviv University Ltd
United States Department of Health and Human Services
Original Assignee
Ramot at Tel Aviv University Ltd
United States Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/324,297 external-priority patent/US6174862B1/en
Application filed by Ramot at Tel Aviv University Ltd, United States Department of Health and Human Services filed Critical Ramot at Tel Aviv University Ltd
Publication of CA2202496A1 publication Critical patent/CA2202496A1/fr
Application granted granted Critical
Publication of CA2202496C publication Critical patent/CA2202496C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002202496A 1994-10-17 1995-10-16 Peptides neurotrophiques du facteur neurotrophique dependant de l'activite Expired - Lifetime CA2202496C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/324,297 US6174862B1 (en) 1991-04-22 1994-10-17 Neurotrophic peptides of activity dependent neurotrophic factor
US08/324,297 1994-10-17
PCT/US1995/012929 WO1996011948A1 (fr) 1994-10-17 1995-10-16 Peptides neurotrophiques du facteur neurotrophique dependant de l'activite

Publications (2)

Publication Number Publication Date
CA2202496A1 CA2202496A1 (fr) 1996-04-25
CA2202496C true CA2202496C (fr) 2010-01-05

Family

ID=29405773

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002202496A Expired - Lifetime CA2202496C (fr) 1994-10-17 1995-10-16 Peptides neurotrophiques du facteur neurotrophique dependant de l'activite

Country Status (1)

Country Link
CA (1) CA2202496C (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008084483A1 (fr) 2007-01-11 2008-07-17 Ramot At Tel Aviv University Ltd. Nouveaux traitements thérapeutiques basés sur la dynamique de tau/des microtubules
EP2467397A1 (fr) 2009-08-17 2012-06-27 Ramot at Tel-Aviv University Ltd. Analogue nap d'acide alpha-aminoisobutyrique avec une activité neuroprotectrice
WO2012015910A2 (fr) 2010-07-28 2012-02-02 Allon Therapeutics Inc. Utilisation de polypeptides adnf pour traitement de maladies neurodégénératives

Also Published As

Publication number Publication date
CA2202496A1 (fr) 1996-04-25

Similar Documents

Publication Publication Date Title
EP0797590B1 (fr) Peptides neurotrophiques du facteur neurotrophique dependant de l'activite
AU2020363214B2 (en) Active polypeptide compound
CA1270598A (fr) Analogue de la gh-rh et procede de preparation
IE62744B1 (en) Lhrh antagonists, a process for preparing them and corresponding pharmaceutical preparations
JPH0532696A (ja) 副甲状腺ホルモン誘導体
IE840867L (en) Peptides
US5106834A (en) Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
IL98638A (en) Analogs of the factor that releases human growth hormone, their preparation and pharmaceutical preparations that contain them
CA2182795C (fr) Antagonistes superactifs du polypeptide intestinal vasoactif
KR100629013B1 (ko) Ｉｇｆ-ⅰ 및 -ⅱ를 억제하는 ｇｈ-ｒｈ의 길항 유사체
EP0672054A1 (fr) Nouvelle molecule inhibant la fonction biologique du neuropeptide tyrosine
EP0341962B1 (fr) Antagonistes du facteur humoral hypercalcémique
HUT55803A (en) Process for producing vip-analogues ii
US20070287665A1 (en) Urotensin-II agonists and antagonists
AU8237187A (en) Derivatives of atrial natriuretic peptides
EP0384731B1 (fr) Facteurs de croissance ostéogéniques identifiés à partir de moelle osseuse régénératrice
WO2003037928A2 (fr) Nouveaux peptides, analogues de l'hormone de liberation de l'hormone de croissance
AU2002232903A1 (en) Urotensin-II agonists and antagonists
CA2030795C (fr) Nouveau peptide physiologiquement actif; agent regulateur du metabolisme du calcium, renfermant ledit peptide comme ingredient actif
RU95120588A (ru) Циклогексапептиды, их смеси, способ их получения и применения
RU2119800C1 (ru) Аналог пептида фактора гормона роста (фгр), способ стимулирования секреции гормона роста и композиция для стимулирования секреции
JPH0421699A (ja) カルシトニン遺伝子関連ペプチド誘導体
EP1878743A2 (fr) Agonistes et antagonistes de l'urotensine II
HK1107571A (en) Urotensin-ii agonists and antagonists

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20151016